|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Hypertrophic Cardiomyopathy | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Cardiomyopathies | |||||
| Cardiomyopathy, Hypertrophic | |||||
| Hypertrophy | |||||
| 3 | More general conditions related to this trial | ||||
| Aortic Stenosis, Subvalvular | |||||
| Aortic Valve Stenosis | |||||
| Cardiovascular Diseases | |||||
| Heart Diseases | |||||
| Heart Valve Diseases | |||||
| Pathological Conditions, Anatomical | |||||
| 4 | Interventions listed in this trial | ||||
| pacemaker implantation | |||||
| 5 | Sponsors listed in this trial | ||||
| National Heart, Lung, and Blood Institute (NHLBI) | |||||